1 day ago - The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up treatment access to more patients.

10 hours ago - Considering Novo Nordisk is already a leader in the GLP-1 space, today's news that its once-a-day oral Wegovy pill has been approved by the FDA is a significant step in helping the company maintain its leadership position.

10 hours ago - The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs.

11 hours ago - A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for health care

8 hours ago - "The FDA approval of Wegovy pill -- the first oral GLP-1 for adults with obesity and overweight with weight-related medical problems -- has the potential to impact millions of Americans," Dave Moore, executive vice president of Novo Nordisk ...

1 hour ago - The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events.

17 hours ago - The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

The first and only FDA-approved GLP-1 pill to help adults with obesity lose weight and keep it off along with diet and exercise.

17 hours ago - The agency greenlit an oral version of the obesity drug Wegovy.

17 hours ago - Considering Novo Nordisk is already a leader in the GLP-1 space, today's news that its once-a-day oral Wegovy pill has been approved by the FDA is a significant step in helping the company maintain its leadership position.

18 hours ago - Dec 22 (Reuters) - The U.S. Food and Drug Administration approved Novo Nordisk's (NOVOb.CO), opens new tab weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as ...

1 day ago - U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration's approval handed drugmaker Novo Nordisk an edge over rival Eli Lilly in the race to market an obesity pill....

1 day ago - The FDA approval of Wegovy® pill is based on the results from the OASIS 4 phase 3 clinical trial, which was a 64-week medical study that included 307 adults with obesity or overweight with one or more weight-related comorbidities, without diabetes.1

7 hours ago - The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.

November 11, 2025 - FDA Approved: Yes (First approved June 4, 2021) Brand name: Wegovy Generic name: semaglutide Dosage form: Injection Company: Novo Nordisk Treatment for: Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction, Nonalcoholic Steatohepatitis

1 day ago - The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment.